<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The membrane-proximal cytoplasmic region of the granulocyte colony-stimulating factor receptor (G-CSFR) is known to be essential for the proliferation signal, with a more distal region being required for the differentiation signal </plain></SENT>
<SENT sid="1" pm="."><plain>Such a separation of functional domains raises the possibility that mutations occurring at these regions may contribute to cell proliferation in the absence of differentiation, this being the most important characteristic in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we analysed the structural abnormalities at the transmembrane and cytoplasmic region of G-CSFR in a significant number of patients with various <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>When we examined the genomic DNA of G-CSFR obtained from 41 patients with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), 18 with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 7 with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 2 with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and 1 with <z:hpo ids='HP_0011010'>chronic</z:hpo> neutrophilic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, we found a polymorphism in 3 patients, but no significant pathogenic mutations in any patients </plain></SENT>
<SENT sid="4" pm="."><plain>The screening for this polymorphism in 100 hematologically <z:mpath ids='MPATH_458'>normal</z:mpath> controls revealed that it may be useful as a linkage marker for population and family studies, because the heterozygosity index is at a high level (0.055) </plain></SENT>
<SENT sid="5" pm="."><plain>While there have been several reports discussing the leukemogenic potential of mutations in the cytokine/hematopoietin receptor superfamily, genetic alterations in the transmembrane and cytoplasmic region of G-CSFR do not seem to play a pathogenic role in <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>